Merger augurs "new era" in UK cancer research:
This article was originally published in Clinica
The UK leading cancer charities Cancer Research Campaign and Imperial Cancer Research Fund are to join together as Cancer Research UK. The merger, due to take effect in early February 2002, will have an annual R&D budget of £130 million ($186 million), making it the "biggest independent cancer research organisation in the world", say the charities. With a "shared vision to conquer cancer through world class research", they aim to combine their complementary strengths to "push through new and effective treatments faster than ever before". Imperial Cancer is considered to be at the forefront of exploratory science, while the CRC is described as Europe`s leader in anti-cancer drug development. The Medical Research Council (MRC) has welcomed the news. Professor Sir George Radda, MRC chief executive and current chair of the National Cancer Research Institute, billed it a "new era in cancer research".
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.